The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis
- PMID: 16784745
- DOI: 10.1016/j.fertnstert.2006.02.082
The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis
Abstract
This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
